Orchestra BioMed CEO, Chair David P. Hochman buys $47,900 common shares

PUBT · 1d ago
Orchestra BioMed CEO, Chair David P. Hochman buys $47,900 common shares
  • Orchestra BioMed CEO and Chairperson David P. Hochman bought 10,000 common shares at a weighted average price of $4.79.
  • Directly held common shares rose to 1,070,746.
  • Indirect holdings totaled 445,339 shares via family trusts.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-105690), on September 08, 2026, and is solely responsible for the information contained therein.